Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
One of the possible bene?ts of 30 years of medical practice is the ability to develop some sense of perspectivewith regardto majortransitionsin medicine. Manyphy- cians who graduated from medical school in the mid- to late 1970s may recall fe- ing less than comfortable about counseling patients regarding lifestyle modi?cation and heart disease risk. A total cholesterol of 250 mg% at that time was considered within normal limits. The best information on the causation of heart disease came from epidemiologic data showing associations between increased consumption of dairy products and fat in the…mehr
One of the possible bene?ts of 30 years of medical practice is the ability to develop some sense of perspectivewith regardto majortransitionsin medicine. Manyphy- cians who graduated from medical school in the mid- to late 1970s may recall fe- ing less than comfortable about counseling patients regarding lifestyle modi?cation and heart disease risk. A total cholesterol of 250 mg% at that time was considered within normal limits. The best information on the causation of heart disease came from epidemiologic data showing associations between increased consumption of dairy products and fat in the industrialized countries of northern Europe and Am- ica, and a corresponding increase in morbidity and mortality from heart disease as compared to other countries that were less well developed or as compared to Mediterranean countries, where there was a different type of diet lower in saturated fats and cholesterol. Treatment options in those days were based more on anecdotal information and observation than on evidence. The idea that coronary artery disease was an in?- matory problem in which the main culprit was oxidized LDL and the idea that heart disease risk could be managed had not yet made the transition to clinical pr- tice. This attitude all changed as information from the largest and longest running prospective epidemiologic study on heart disease—the Framingham Study—began publishing data on causality and risk factors.
Lipid disorders impact an estimated 42 to 50 million adults in the United States, yet many primary care physicians are not optimally treating this growing population. This superb volume is a major contribution to the treatment of this genre of disorders. It is a comprehensive resource for primary care providers that offers information and treatment options that can be incorporated with ease into everyday clinical practice. This evidence-based text weighs the benefits of pharmacologic treatments, popular diets, therapeutic foods, herbs and vitamins as a means to manage hyperlipidemia. A section dedicated to treating special populations examines the particular needs of elderly patients, women, athletes and other unique groups. Complete with clinical case studies to illustrate real-life patient scenarios, Hyperlipidemia Management for Primary Care is a handy reference for any physician seeking clear cut information on this increasingly common condition.
Inhaltsangabe
Overview of Evidence Supporting the Treatment of Hyperlipidemia.- National Cholesterol Education Program: Adult Treatment Panel III Guidelines and the 2004 Update.- Dietary Interventions.- Therapeutic Foods.- Exercise Interventions to Reduce Lipids and Cardiovascular Disease Risk.- Drug Treatment.- Special Populations.- New Issues in the Screening and Prevention of Cardiovascular Disease.- Practical Approach to the Patient with Hyperlipidemia.- Cases.- Future Directions.
Overview of Evidence Supporting the Treatment of Hyperlipidemia.- National Cholesterol Education Program: Adult Treatment Panel III Guidelines and the 2004 Update.- Dietary Interventions.- Therapeutic Foods.- Exercise Interventions to Reduce Lipids and Cardiovascular Disease Risk.- Drug Treatment.- Special Populations.- New Issues in the Screening and Prevention of Cardiovascular Disease.- Practical Approach to the Patient with Hyperlipidemia.- Cases.- Future Directions.
Overview of Evidence Supporting the Treatment of Hyperlipidemia.- National Cholesterol Education Program: Adult Treatment Panel III Guidelines and the 2004 Update.- Dietary Interventions.- Therapeutic Foods.- Exercise Interventions to Reduce Lipids and Cardiovascular Disease Risk.- Drug Treatment.- Special Populations.- New Issues in the Screening and Prevention of Cardiovascular Disease.- Practical Approach to the Patient with Hyperlipidemia.- Cases.- Future Directions.
Overview of Evidence Supporting the Treatment of Hyperlipidemia.- National Cholesterol Education Program: Adult Treatment Panel III Guidelines and the 2004 Update.- Dietary Interventions.- Therapeutic Foods.- Exercise Interventions to Reduce Lipids and Cardiovascular Disease Risk.- Drug Treatment.- Special Populations.- New Issues in the Screening and Prevention of Cardiovascular Disease.- Practical Approach to the Patient with Hyperlipidemia.- Cases.- Future Directions.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309